State Street’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.6K Hold
26,152
﹤0.01% 4116
2026
Q1
$26.4K Hold
26,152
﹤0.01% 4196
2025
Q4
$22K Hold
26,152
﹤0.01% 4240
2025
Q3
$33.2K Hold
26,152
﹤0.01% 4203
2025
Q2
$34.5K Hold
26,152
﹤0.01% 4145
2025
Q1
$25.9K Hold
26,152
﹤0.01% 4179
2024
Q4
$33.7K Hold
26,152
﹤0.01% 4172
2024
Q3
$27.7K Hold
26,152
﹤0.01% 4187
2024
Q2
$29.6K Buy
26,152
+7,300
+39% +$8.96K ﹤0.01% 4230
2024
Q1
$25.3K Hold
18,852
﹤0.01% 4267
2023
Q4
$43.2K Hold
18,852
﹤0.01% 4220
2023
Q3
$23.8K Buy
+18,852
New +$33.9K ﹤0.01% 4425

Other funds holding RNXT

State Street's RNXT Position: Q2 2026 in Review

State Street held its RenovoRx (RNXT) position steady in Q2 2026 at 26,152 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4116.

State Street first reported a position in RNXT in Q3 2023 and has held it in 12 quarters since. The position peaked at $43.2K in Q4 2023. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • State Street held 26,152 shares of RenovoRx worth $25.6K as of Q2 2026.
  • State Street left its RenovoRx share count unchanged in Q2 2026.
  • RenovoRx made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4116 holding.
  • State Street first reported a position in RenovoRx in Q3 2023 and has held it in 12 quarters since.
  • State Street's RenovoRx position peaked at $43.2K in Q4 2023.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.